Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Nelkin

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
The Journal of Clinical Investigation|February 14, 1998
Activated Raf-1 causes growth arrest in human small cell lung cancer cellsR K Ravi, E Weber, M McMahon, et al.
Carcinogenesis|June 1, 1989
Computational analysis of structural and energetic consequences of DNA methylationF H Hausheer, S N Rao, M P Gamcsik, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1985
Linkage map of the short arm of human chromosome 11: location of the genes for catalase, calcitonin, and insulin-like growth factor IIS D Kittur, J W Hoppener, S E Antonarakis, et al.
Gene|June 16, 2000
Cloning and chromosomal localization of the human BARX2 homeobox protein geneA Krasner, L Wallace, A Thiagalingam, et al.
Cancer Biology & Therapy|July 20, 2011
Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft modelsGeorg Feldmann, Anjali Mishra, Savita Bisht, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2019
A Phase I Trial of the VEGF Receptor Tyrosine Kinase Inhibitor Pazopanib in Combination with the MEK Inhibitor Trametinib in Advanced Solid Tumors and Differentiated Thyroid CancersRazelle Kurzrock, Douglas W Ball, Marianna L Zahurak, et al.
The Journal of Clinical Investigation|August 22, 2018
O-GlcNAcylation is required for mutant KRAS-induced lung tumorigenesisKekoa Taparra, Hailun Wang, Reem Malek, et al.
Cancer Biology & Therapy|September 7, 2010
The Axl receptor tyrosine kinase is an adverse prognostic factor and a therapeutic target in esophageal adenocarcinomaAlvarez Hector, Elizabeth A Montgomery, Collins Karikari, et al.
The Journal of Clinical Endocrinology and Metabolism|December 25, 2012
Exomic sequencing of medullary thyroid cancer reveals dominant and mutually exclusive oncogenic mutations in RET and RASNishant Agrawal, Yuchen Jiao, Mark Sausen, et al.
Nature|February 28, 2020
Epigenetic therapy inhibits metastases by disrupting premetastatic nichesZhihao Lu, Jianling Zou, Shuang Li, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
The Journal of Clinical Investigation|February 14, 1998
Activated Raf-1 causes growth arrest in human small cell lung cancer cellsR K Ravi, E Weber, M McMahon, et al.
Carcinogenesis|June 1, 1989
Computational analysis of structural and energetic consequences of DNA methylationF H Hausheer, S N Rao, M P Gamcsik, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1985
Linkage map of the short arm of human chromosome 11: location of the genes for catalase, calcitonin, and insulin-like growth factor IIS D Kittur, J W Hoppener, S E Antonarakis, et al.
Gene|June 16, 2000
Cloning and chromosomal localization of the human BARX2 homeobox protein geneA Krasner, L Wallace, A Thiagalingam, et al.
Cancer Biology & Therapy|July 20, 2011
Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft modelsGeorg Feldmann, Anjali Mishra, Savita Bisht, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2019
A Phase I Trial of the VEGF Receptor Tyrosine Kinase Inhibitor Pazopanib in Combination with the MEK Inhibitor Trametinib in Advanced Solid Tumors and Differentiated Thyroid CancersRazelle Kurzrock, Douglas W Ball, Marianna L Zahurak, et al.
The Journal of Clinical Investigation|August 22, 2018
O-GlcNAcylation is required for mutant KRAS-induced lung tumorigenesisKekoa Taparra, Hailun Wang, Reem Malek, et al.
Cancer Biology & Therapy|September 7, 2010
The Axl receptor tyrosine kinase is an adverse prognostic factor and a therapeutic target in esophageal adenocarcinomaAlvarez Hector, Elizabeth A Montgomery, Collins Karikari, et al.
The Journal of Clinical Endocrinology and Metabolism|December 25, 2012
Exomic sequencing of medullary thyroid cancer reveals dominant and mutually exclusive oncogenic mutations in RET and RASNishant Agrawal, Yuchen Jiao, Mark Sausen, et al.
Nature|February 28, 2020
Epigenetic therapy inhibits metastases by disrupting premetastatic nichesZhihao Lu, Jianling Zou, Shuang Li, et al.
Pageof 11